BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 20071465)

  • 1. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.
    Aki K; Shimizu A; Masuda Y; Kuwahara N; Arai T; Ishikawa A; Fujita E; Mii A; Natori Y; Fukunaga Y; Fukuda Y
    Am J Physiol Renal Physiol; 2010 Apr; 298(4):F870-82. PubMed ID: 20071465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
    Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
    Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
    Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T
    Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis.
    Shimizu A; Masuda Y; Mori T; Kitamura H; Ishizaki M; Sugisaki Y; Fukuda Y
    J Am Soc Nephrol; 2004 Oct; 15(10):2655-65. PubMed ID: 15466270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis.
    Odobasic D; Kitching AR; Semple TJ; Timoshanko JR; Tipping PG; Holdsworth SR
    J Am Soc Nephrol; 2005 Jul; 16(7):2012-22. PubMed ID: 15944341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Suppressive effects of GTW treatment on infiltration of inflammatory cell in glomeruli in anti-Thy1.1 glomerulonephritis].
    Wan Y; Sun W; Che X; Yang H; Ge M; Dai W; Shimizu F
    Zhongguo Zhong Yao Za Zhi; 2009 Jan; 34(1):72-7. PubMed ID: 19382456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages.
    Fujita E; Shimizu A; Masuda Y; Kuwahara N; Arai T; Nagasaka S; Aki K; Mii A; Natori Y; Iino Y; Katayama Y; Fukuda Y
    Am J Pathol; 2010 Sep; 177(3):1143-54. PubMed ID: 20696778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crucial role of CD8-positive lymphocytes in glomerular expression of ICAM-1 and cytokines in crescentic glomerulonephritis of WKY rats.
    Fujinaka H; Yamamoto T; Feng L; Kawasaki K; Yaoita E; Hirose S; Goto S; Wilson CB; Uchiyama M; Kihara I
    J Immunol; 1997 May; 158(10):4978-83. PubMed ID: 9144517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats.
    Kovalenko P; Fujinaka H; Yoshida Y; Kawamura H; Qu Z; El-Shemi AG; Li H; Matsuki A; Bilim V; Yaoita E; Abo T; Uchiyama M; Yamamoto T
    Int Immunol; 2004 May; 16(5):625-34. PubMed ID: 15096492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.
    Wolf D; Hochegger K; Wolf AM; Rumpold HF; Gastl G; Tilg H; Mayer G; Gunsilius E; Rosenkranz AR
    J Am Soc Nephrol; 2005 May; 16(5):1360-70. PubMed ID: 15788479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical characterization of glomerular inflammatory cells and expression of adhesion molecules in anti-glomerular basement membrane (anti-GBM) glomerulonephritis induced in WKY rats with monoclonal anti-GBM antibodies of different subclasses.
    Kado T; Kohda T; Okada S; Hayashi A; Utsunomiya Y; Kanzaki S; Sado Y; Yamamoto T
    Pathol Int; 2006 Feb; 56(2):55-61. PubMed ID: 16445816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crescentic glomerulonephritis in CD4- and CD8-deficient mice. Requirement for CD4 but not CD8 cells.
    Tipping PG; Huang XR; Qi M; Van GY; Tang WW
    Am J Pathol; 1998 Jun; 152(6):1541-8. PubMed ID: 9626058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
    Urushihara M; Ohashi N; Miyata K; Satou R; Acres OW; Kobori H
    Hypertension; 2011 Mar; 57(3):586-93. PubMed ID: 21282555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression.
    Mii A; Shimizu A; Masuda Y; Ishizaki M; Kawachi H; Iino Y; Katayama Y; Fukuda Y
    Lab Invest; 2009 Feb; 89(2):164-77. PubMed ID: 19139720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-perforin antibody treatment ameliorates experimental crescentic glomerulonephritis in WKY rats.
    Fujinaka H; Yamamoto T; Feng L; Nameta M; Garcia G; Chen S; El-shemi AA; Ohshiro K; Katsuyama K; Yoshida Y; Yaoita E; Wilson CB
    Kidney Int; 2007 Oct; 72(7):823-30. PubMed ID: 17622272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats.
    Yamahana J; Wada T; Furuichi K; Sakai N; Yokoyama H; Kaneko S
    Nephrol Dial Transplant; 2006 Oct; 21(10):2736-44. PubMed ID: 16891648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis.
    Tipping PG; Kitching AR; Huang XR; Mutch DA; Holdsworth SR
    Eur J Immunol; 1997 Feb; 27(2):530-7. PubMed ID: 9045927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-18 translational inhibition restricts IFN-gamma expression in crescentic glomerulonephritis.
    Garcia GE; Xia Y; Ku G; Johnson RJ; Wilson CB; Feng L
    Kidney Int; 2003 Jul; 64(1):160-9. PubMed ID: 12787406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.